Le. Dyck et Ba. Davis, Inhibition of rat liver microsomal CYP1A2 and CYP2B1 activity by N-(2-heptyl)-N-methyl-propargylamine and by N-(2-heptyl)-propargylamine, DRUG META D, 29(8), 2001, pp. 1156-1161
(R)-N-(2-Heptyl)-N-methyl-propargylamine (R-2HMP) and (R)-N-(2-heptyl)-prop
argylamine (R-2HPA) are analogs of R-deprenyl. R-Deprenyl, a selective mono
amine oxidase B inhibitor, is a mechanism-based inactivator of purified CYP
2B1. The aim of the present study was to determine whether R-2HMP and R-2HP
A behaved like deprenyl with respect to inhibiting cytochrome P450 (CYP450)
enzyme activity. The activities of CYP1A2 and CYP1A1 were assessed by meas
uring the deethylation of 7-ethoxyresorufin by liver microsomes obtained fr
om control and beta -naphthoflavone-treated female Wistar rats, respectivel
y. CYP2B1 activity was assessed by measuring depentylation of 7-pentoxyreso
rufin by liver microsomes obtained from phenobarbital-treated rats. The act
ivity of CYP1A1 was unaffected by 100 muM concentrations of R-deprenyl, R-2
HMP, or R-SHPA. In contrast, the activities of CYP1A2 and CYP2B1 were signi
ficantly decreased. In general, the percentage of CYP1A2 activity remaining
in the presence of 100 muM of one of these propargylamines ranged from 45
to 56%, whereas 10% or less of CYP2B1 activity remained. No marked differen
ces between the various propargylamines were observed. The IC50 values for
the inhibition of CYP2B1 activity by R-deprenyl, R-2HMP, and R-2HPA were fo
und to be 2.6, 8.5, and 3.6 muM, respectively. The S-enantiomers of depreny
l, 2HMP, and 2HPA also inhibited the activity of microsomal CYP2B1. R-2HMP,
R-2HPA, and S-2HPA were found to be mechanism-based inactivators of CYP2B1
activity. The inactivation constants k(inact) and K-1 were found to be as
follows: R-deprenyl, 1.3 muM and 0.32 min(-1); R-2HMP, 0.8 muM and 0.08 min
(-1); R-2HPA, 0.5 muM and 0.36 min(-1); and S-2HPA, 0.24 muM and 0.18 min(-
1).